REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Bridging Bioactive Metabolites of Phoenix dactylifera L. with Advanced Nanocarrier Technologies for Mucoadhesive Drug Delivery
Provisionally accepted
- 1KBHSS Trust's Institute of Pharmacy, Maharashtra, India
- 2University of Hail, Hail, Saudi Arabia
- 3Biotechnology Institute, Ankara University, Ankara, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Phoenix dactylifera L. (PD), a monocotyledonous flowering plant from the Arecaceae family, is one of fourteen species in the Phoenix genus and has been cultivated in the Middle East for over 6000 years. Its fruit is regarded as a complete food due to its rich nutritional and medicinal profile, containing flavonoids, carotenoids, procyanidins, phenolics, sterols, anthocyanins, steroids, fatty acids, proteins, and amino acids. These bioactive metabolites contribute to its therapeutic potential, particularly in anticancer applications. To enhance the effectiveness of such natural metabolites in medical treatments, Nano-Drug Delivery Systems (NDDS) have gained significant attention, offering controlled drug release, increased permeability and retention, prolonged circulation time, and reduced degradation. This review employed a comprehensive literature search across databases such as Web of Science, PubMed, Google Scholar, and Scopus, using keywords like "Phoenix dactylifera," "date palm," "Ajwa," "natural products," "NDDS," and "Drug Delivery System," focusing on relevant publications from January 1995 to May 2025. It presents an up-to-date overview of the pharmacological properties of PD metabolites and explores various innovative NDDS formulations including phytosomes, liposomes, microspheres, ethosomes, solid lipid nanoparticles, niosomes, proniosomes, dendrimers, and liquid crystals as potential strategies to improve the delivery and efficacy of PD-based therapies. Additionally, the review discusses the advantages and limitations of these delivery systems in the context of developing PD bioactives as a viable anticancer agent.
Keywords: cytotoxic, date palm, Delivery Systems, Natural Products, NDSS, Pharmacological effect, Phoenix dactylifera
Received: 18 Nov 2025; Accepted: 05 Feb 2026.
Copyright: © 2026 Helal Ahmed, Gangurde, Hussain, Atalay, Bender and Anwar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Onur Bender
Sirajudheen Anwar
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.